Information:
Error:
ID
32706
Description
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Keywords
Versions (1)
- 11/13/18 11/13/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 13, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Estimation of Dose Proportionality of Darapladib - 107038
Logs and Repeats: General Adverse Event and Concomitant Medication Questions
Similar models
Logs and Repeats: General Adverse Event and Concomitant Medication Questions
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date below is the start of the study for this subject
Item
Date below is the start of the study for this subject
date
Item Group
Adverse Event/Concomitant Medications/Repeat Assessment (Check Questions)
Were any concomitant medications taken by the subject during the study?
Item
Were any concomitant medications taken by the subject during the study?
boolean
Did the subject experience any adverse events during the study?
Item
Did the subject experience any adverse events during the study?
boolean
Were any repeat ECGs performed?
Item
Were any repeat ECGs performed?
boolean
Were any repeat/unscheduled PK samples taken?
Item
Were any repeat/unscheduled PK samples taken?
boolean
Were any repeat/unscheduled PD samples taken?
Item
Were any repeat/unscheduled PD samples taken?
boolean
No comments